Exocarpium Citri Grandis ameliorates LPS-induced acute lung injury by suppressing inflammation, NLRP3 inflammasome, and ferroptosis
Datos Bibliográficos
| ID | 14729360 |
|---|---|
| Autores | Zaibin Xu (Guangzhou University of Chinese Medicine), Jiayu Li (0000-0001-9572-1852, Guangzhou University of Chinese Medicine), Kaili Zhou (Guangzhou University of Chinese Medicine), Kongyan Wang (Guangzhou University of Chinese Medicine), Huiyu Hu (0000-0003-2866-9358, Guangzhou University of Chinese Medicine), Yingjie Hu (0000-0002-5515-4125, Guangzhou University of Chinese Medicine, autor de correspondencia), Yong Gao (0000-0003-0067-9626, Guangzhou University of Chinese Medicine, autor de correspondencia), Zhuohui Luo (Hainan Medical University, autor de correspondencia), Jiawen Huang (0000-0003-1362-0412, Guangzhou University of Chinese Medicine, autor de correspondencia) |
| Año | 2024 |
| Volumen | 329 |
| Páginas | 118162 |
| Fecha de publicación | 2024-07-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Journal of Ethnopharmacology (JOURNAL) |
| Identificadores de la revista | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2024.118162 |
| PMID | 38588989 |
| OpenAlex | W4394062187 |
| Idioma | EN |
| Citas recibidas | 2 |
| Referencias citadas | 47 |
Biology · In vivo · Inflammation · Oxidative stress · Proinflammatory cytokine · Thioredoxin · TLR4 · TXNIP · Western blot · Cancer-related molecular mechanisms research · Chemistry · Immune Response and Inflammation · Inflammasome and immune disorders · Medicine · Biochemistry · Immunology · Internal Medicine · Pharmacology
Prophylactic isoimperatorin protects against LPS-ALI via mTOR-dependent control of inflammation, oxidative stress and ferroptosis markers
An integrated approach of experiment validation and single-cell RNA sequencing reveal dual-pathway inhibition of NLRP3/ferroptosis by flavonoids of Sanyeqing fibrous root in acute lung injury
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 2 |
| Intervalo de citas | 2026 - 2026 (1) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 2 |